These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation. Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612 [TBL] [Abstract][Full Text] [Related]
3. More than skin deep: Mucosal pathology in facial vascularized composite allografts. Commentary on "Pathologies of oral and sinonasal mucosa following facial vascularized composite allotransplantation". Leonard DA; Colvin RB J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1572-1573. PubMed ID: 33414096 [No Abstract] [Full Text] [Related]
15. Regulatory oversight in the United States of vascularized composite allografts. Glazier AK Transpl Int; 2016 Jun; 29(6):682-5. PubMed ID: 26284312 [TBL] [Abstract][Full Text] [Related]
16. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation. Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033 [TBL] [Abstract][Full Text] [Related]
17. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714 [TBL] [Abstract][Full Text] [Related]
18. Vascularized composite allografts and solid organ transplants: similarities and differences. Weissenbacher A; Hautz T; Pratschke J; Schneeberger S Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807 [TBL] [Abstract][Full Text] [Related]
19. Vascularized composite allograft-specific characteristics of immune responses. Issa F Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941 [TBL] [Abstract][Full Text] [Related]
20. Vascularized Composite Allograft Transplantation in the United States: Current State of the Field and Future Challenges. Wainright JL; Booker SE; Cherikh WS; Klassen DK Transplantation; 2022 Nov; 106(11):2093-2096. PubMed ID: 36279554 [No Abstract] [Full Text] [Related] [Next] [New Search]